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 A 55-year-old woman with a progressive gait disorder and dif-
fi culties in executing skilled movements with her right hand for 12 
months was admitted for further evaluation. The patient had no 
previous history of stroke, Bell’s palsy or other neurological dis-
eases.  
 On admission, the neurological examination revealed a cog-
wheel rigidity and bradykinesia of the right upper and lower ex-
tremities. Reduced and slowed movements of the right-sided facial 
muscles were also observed, but only of the lower face ( fi g. 1 ). Both 
hypokinesia and bradykinesia were most pronounced when the pa-
tient spoke. Voluntary facial movements were less affected when 
she followed instructions; this was also the case for emotional 
movements (e.g., refl ex smiling). 
 While the cranial MRI was normal, DaTSCAN-SPECT showed 
an asymmetry of the presynaptic dopamine transporter in the stri-
atal region; there was a signifi cantly lower intensity on the left side. 
The patient was diagnosed to have Parkinson’s disease (PD) and 
was initially treated with levodopa (Madopar, 625 mg daily) and a 
dopamine agonist (Cabergoline, 0.5 mg per day). During this treat-
ment, the hypokinesia and bradykinesia of the right upper and 
lower extremities and the right-sided hypomimia improved sig-
nifi cantly.  
 A lateralization of motor signs in PD has only been reported to 
occur as an asymmetric hypo- and bradykinesia of the limbs, in 
particular as a typical feature of the early stages of PD  [1, 2] . In our 
patient, the unilateral hypo- and bradykinesia also manifested in 
the lower face on the same side.  
 Parkinsonian bradykinesia is characterized by two main fea-
tures: (1) patients underscale muscle force and (2) the defi cit is often 
ameliorated when external cues are given to guide the movements. 
Generally, the basal ganglia motor output has access to the medial 
rather than the lateral motor cortical areas. Metabolic studies in 
patients with PD showed that there is underactivity of midline cor-
tical motor areas (supplementary motor cortex), which is some-
times accompanied by an increase in activation of lateral premotor 
areas. This increased activation might be an active process of com-
pensation and related to the improvement in performance that can 
be observed when external cues are given to guide movements
 [3, 4] . 
 Medial cortical areas are more active in association with inter-
nally generated movements, whereas lateral areas are more active 
during externally cued movements. Underscaling of muscle force 
seems to be a particular problem in internally generated move-
ments (e.g., facial expression while speaking)  [5] . The underscaling 
of muscle force seems less of a problem when movements are ex-
ternally cued. This was obvious in our patient whose voluntary 
facial movements were less affected when following instructions, 
whereas the hypo- and bradykinesia were best observed when the 
patient spoke. The sparing of the upper face might be explained by 
the fact that it is innervated bilaterally from the primary motor 
cortex  [6] .  
 Fig. 1. The 55-year-old patient, who was diagnosed to have PD, 
exhibits hemihypomimia of the right-sided facial muscles when 
speaking. 
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 In conclusion, this is an exceptional case of right-sided hemipar-
kinsonism with an obvious unilateral brady- and hypokinesia of the 
face on the same side, i.e., hemihypomimia. Since this phenome-
non has not yet been described in detail in the literature, the subtle 
lateralization of hypomimia may remain undetected in patients 
with PD – in particular, as a sign in the early stages of unilateral 
PD. It should, however, be considered in patients with PD. 
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 Introduction 
 Metronidazole is a 5-nitroimidazole antibiotic with neurologi-
cal side-effects including neuropathy, seizures, encephalopathy and 
cerebellar dysfunction. Central nervous system (CNS) toxicity is 
rare. Magnetic resonance imaging (MRI) has shown variable supra-
tentorial white matter lesions, including the corpus callosum and 
cerebellar grey matter lesions mainly involving the dentate nuclei. 
We report marked but reversible visual defi cit, cerebellar and neu-
ropathy symptoms after years of metronidazole treatment at nor-
mal doses. 
 Case Report 
 A 20-year-old man with ulcerative colitis complained of de-
creased visual acuity for 2 months. He had painful distal paraes-
thesia for 1 year. During the last few months, he had developed 
dysarthria and impaired coordination with both hands. He had 
been on metronidazole 1,500 mg daily for 2 years. The ophthal-
mologist noted a vision of 2/10 bilaterally and major disturbance 
of red-green colour discrimination. Pattern visual evoked poten-
tials (VEPs) were absent ( fi g. 1 ), but low-amplitude fl ash VEPs were 
elicited with markedly prolonged latencies. MRI of the brain and 
optic nerves showed non-enhancing increased signal intensities on 
sagittal T 2 -weighted images in the splenium and less conspicuously 
in the truncus and genu of the corpus callosum ( fi g. 2 A) and normal 
optic nerves. Metronidazole was discontinued. 
 Two weeks later, when examined in the neurology department, 
vision had recovered to 8/10. Neither nystagmus nor other gaze 
abnormalities were observed. Limb coordination was slightly im-
paired. Sensory testing revealed dysaesthesia and allodynia at all 
extremities and astereognosia on both hands. Tendon refl exes were 
weak or absent.  
 Cerebrospinal fl uid was normal, with no abnormalities on im-
munoelectrophoresis. Pattern VEPs could be elicited with low am-
plitudes and markedly increased P 1  latencies ( fi g. 1 ). Brainstem and 
somatosensory evoked potentials were normal. Electromyography 
revealed a purely sensory distal symmetric axonal neuropathy. 
 Repeat brain MRI scan after 2 and 8 months showed gradual 
though incomplete resolution of the increased signal in the corpus 
callosum ( fi g. 2 B, C). The painful paraesthesia disappeared within 
3 months after cessation of metronidazole. After 14 months, all 
other symptoms and signs had resolved and pattern VEP latencies 
had normalised ( fi g. 1 ). No visual or CNS symptoms or signs have 
recurred in a 3-year follow-up period. 
 Discussion 
 The incidence of metronidazole-induced CNS toxicity is low as 
compared with neuropathy, which is usually a distal symmetric 
sensory neuropathy with mainly small-fi bre involvement and sub-
clinical large-fi bre involvement. Rare cases with metronidazole-re-
lated CNS toxicity have shown involvement of the corpus callosum. 
In 1995, Ahmed et al.  [1]  reported a patient with nausea, vomiting, 
confusion, ataxia, neuropathy and MRI lesions that symmetrically 
involved the supratentorial white matter, the corpus callosum and 
deep cerebellar grey nuclei. As in our patient, the lesions regressed 
after stopping metronidazole. The few other cases confi rm ataxia 
and dysarthria as common symptoms and illustrate that the supra-
tentorial white matter and cerebellar dentate nuclei are often in-
volved  [2–5] . 
 Our patient presented with focal corpus callosum lesions main-
ly affecting the splenium. Multiple sclerosis is by far the most com-
mon disease with corpus callosum hyperintensities on T 2 -weighted 
MRI. Transient T 2 -weighted MRI hyperintensities in the splenium 
of the corpus callosum have rarely been reported in epilepsy pa-
tients and have been ascribed to vasogenic oedema due to anti-
epileptic drug toxicity possibly facilitated by vitamin defi ciency  [6] . 
The absence of oligoclonal banding in the cerebrospinal fl uid, the 
reversibility of the clinical signs and symptoms, the reversible non-
contrast enhancing MRI lesions and the absence of new neurologi-
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